The two faces of Rsk2 in hyperplastic disease
Falconer, Jane and Buckley, CD (2015) The two faces of Rsk2 in hyperplastic disease. Nature Reviews Rheumatology. ISSN 1759-4804
Item Type: | Article |
---|
Abstract
Given the established role of 90 kDa ribosomal S6 kinases (Rsk) in oncogenesis, and the promise of new Rsk-blocking cancer treatments, it is perhaps surprising that Rsk2-mediated inhibition of hyperplasia has now been demonstrated to occur in the arthritic synovium. Does this functional duality make Rsk2 a risky target for the treatment of rheumatoid arthritis?
PDF (News and Views Article)
nrrheum 2015.1.pdf - Published Version Restricted to Repository staff only Download (165kB) | Request a copy |
More Information
Depositing User: Jane Falconer |
Identifiers
Item ID: 11088 |
Identification Number: https://doi.org/10.1038/nrrheum.2015.1 |
ISSN: 1759-4804 |
URI: http://sure.sunderland.ac.uk/id/eprint/11088 | Official URL: https://www.nature.com/articles/nrrheum.2015.1 |
Users with ORCIDS
Catalogue record
Date Deposited: 05 Sep 2019 09:45 |
Last Modified: 30 Sep 2020 11:30 |
Author: | Jane Falconer |
Author: | CD Buckley |
University Divisions
Faculty of Health Sciences and Wellbeing > School of MedicineActions (login required)
View Item (Repository Staff Only) |